Oct. 11, 2013
NewsCompany News

Sartorius Stedim Biotech Announces Offer to Acquire TAP Biosystems

Sartorius Stedim Biotech made a cash offer to acquire the UK company TAP Biosystems Group plc (TAP Biosystems) through its wholly owned subsidiary Sartorius Stedim Biotech GmbH.

The proposed transaction, which is subject to customary closing conditions, including the approval of TAP's shareholders, values the equity of TAP Biosystems at approximately €33 million. The transaction has been unanimously approved by the boards of directors of both companies and is expected to close at the end of 2013.

Read more on this topic at http://www.sartorius.com/

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.